President Trump Expected to Nominate Heidi Overton for FDA Leadership
President Trump is expected to nominate White House adviser Heidi Overton to lead the Food and Drug Administration (FDA). Overton currently serves as deputy director of the White House Domestic Policy Council and has previously held positions in the Trump…
Cleveland Akron, OH, August 19, 2026 —
President Donald Trump is reportedly preparing to nominate White House adviser Heidi Overton to serve as the next commissioner of the Food and Drug Administration (FDA), according to sources familiar with the matter. Overton currently holds the position of deputy director of the White House Domestic Policy Council.
Overton’s previous experience includes roles within the Trump administration, though specific details of these past positions were not provided in the summary. Her policy perspectives are noted to include opposition to abortion rights. Additionally, Overton has expressed support for reviewing and potentially altering existing vaccine mandates and schedules.
The nomination, if formally announced, would place a key figure with stated policy preferences on sensitive public health issues at the helm of a critical regulatory agency. The FDA plays a significant role in approving drugs, medical devices, and overseeing food safety, as well as regulating tobacco products and leading public health initiatives.
Further details regarding the timeline for a potential nomination announcement or the specific processes that would follow were not available in the provided summary. The outcome of any such nomination would be subject to confirmation procedures.
Story summarized from the original created by Scripps News Group on www.news5cleveland.com, see more information here.
